Shih‐Te Tu

机构：Centre for Advanced Study, Changhua Christian Hospital, Shenyang Jianzhu University · ORCID：0000-0002-1202-7409

发表论文 126 篇 · 总被引 5931 次 · h-index 29

代表论文

• Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial (2023 · The Lancet · 被引 730)
• Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes (2023 · Annals of Internal Medicine · 被引 95)
• Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial (2025 · Circulation · 被引 59)
• COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics (2025 · Nephrology Dialysis Transplantation · 被引 25)
• Mechanisms of comorbidity between Alzheimer's disease and pain (2025 · Alzheimer s & Dementia · 被引 19)
• Asia-Pacific consensus on long-term and sequential therapy for osteoporosis (2024 · Osteoporosis and Sarcopenia · 被引 19)